Jeffery's mailing address filed with the SEC is 1 World Trade Center, New York, NY 10006, USA.
Over the last 22 years, insiders at Progenics Pharmaceuticals have traded over 11,559,939$ worth of Progenics Pharmaceuticals stock and bought 2,672,016 units worth 11,900,148$ . The most active insiders traders include Healthcare Master Fund Ltd ...、Michael D Kishbauch、Bradley L Campbell. On average, Progenics Pharmaceuticals executives and independent directors trade stock every 16 days with the average trade being worth of 60,241$. The most recent stock trade was executed by Capital, L.P.Altiva Managem... on 9 September 2019, trading 72,023 units of PGNX stock currently worth 359,395$.
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.
Progenics Pharmaceuticals executives and other stock owners filed with the SEC include: